Enovis Corporation (LON:0I1B)

Market Cap	1.41B
Revenue (ttm)	1.66B
Net Income (ttm)	-626.24M
Shares Out	n/a
EPS (ttm)	-11.22
PE Ratio	n/a
Forward PE	11.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16
Average Volume	55
Open	33.17
Previous Close	33.60
Day's Range	33.17 - 33.20
52-Week Range	29.57 - 49.55
Beta	n/a
RSI	50.37
Earnings Date	Aug 7, 2025

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management,...

• Industry: Industrial - Capital Goods
• Sector: Industrials
• Founded: 1995
• Employees: 7,367
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I1B

Financial Performance

In 2024, Enovis's revenue was $2.11 billion, an increase of 23.46% compared to the previous year's $1.71 billion. Losses were -$825.49 million, 2381.9% more than in 2023.

Financial numbers in USD